Lista de obras - Heather Thorne - Dominio Público Uruguay

"Cancer 2015": A Prospective, Population-Based Cancer Cohort-Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic

artículo científico publicado en 2015

A community-based model of rapid autopsy in end-stage cancer patients

artículo científico publicado en 2016

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

artículo científico publicado en 2009

Altered significance of D'Amico risk classification in patients with prostate cancer linked to a familial breast cancer (kConFab) cohort

artículo científico publicado en 2015

Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource

artículo científico publicado en 2006

Biobanking in Cancer Research

artículo científico publicado en 2016

Biochemical characterization of the monoclonal antibody-defined ovarian carcinoma-associated antigen SGA

artículo científico publicado en 1986

Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab

artículo científico publicado en 2016

Children’s Brain Tumour Cells Produce RNA Particles with Incomplete Retrovirus Characteristics ⬇️

artículo científico publicado el 1 de enero de 1982

Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy

artículo científico publicado en 2003

Decreased Prostate Cancer-Specific Survival of Men withBRCA2 Mutations from Multiple Breast Cancer Families

artículo científico publicado en 2011

Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2013

Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.

artículo científico publicado en 2017

High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer

artículo científico publicado en 2012

Histopathological features of breast cancer in carriers of ATM gene variants

scientific article published on 01 November 2006

Improving mutation notification when new genetic information is identified in research: a trial of two strategies in familial breast cancer

artículo científico publicado en 2012

Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells

artículo científico publicado en 2017

Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk

artículo científico publicado en 2012

Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation.

artículo científico

Monoclonal antibody CI-panHu defines a pan-human cell-surface antigen unique to higher primates.

artículo científico publicado en 1986

Multifactorial likelihood assessment of BRCA1 and BRCA2 missense variants confirms that BRCA1:c.122A>G(p.His41Arg) is a pathogenic mutation

artículo científico publicado en 2014

Overexpression of wild-type p53 in lichen sclerosus adjacent to human papillomavirus-negative vulvar cancer

artículo científico publicado en 2002

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes

artículo científico publicado en 2022

Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.

artículo científico publicado en 2014

RAD21 overexpression is frequently observed in BRCA-X Prostate Cancers

article

Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer.

artículo científico publicado en 2015

Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families

artículo científico publicado en 2015

The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".

artículo científico publicado en 2016

The kConFab experience – 14 years of biobanking.

artículo científico publicado en 2012

The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cells

scientific article published on 01 September 1985

Whole-genome characterization of chemoresistant ovarian cancer

artículo científico publicado en 2015

kConFab: A Familial Breast Cancer Consortium Facilitating Research and Translational Oncology

artículo científico publicado en 2011

Lista de obras de Heather Thorne

"Cancer 2015": A Prospective, Population-Based Cancer Cohort-Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic

A community-based model of rapid autopsy in end-stage cancer patients

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

Altered significance of D'Amico risk classification in patients with prostate cancer linked to a familial breast cancer (kConFab) cohort

Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource

Biobanking in Cancer Research

Biochemical characterization of the monoclonal antibody-defined ovarian carcinoma-associated antigen SGA

Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab

Children’s Brain Tumour Cells Produce RNA Particles with Incomplete Retrovirus Characteristics ⬇️

Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy

Decreased Prostate Cancer-Specific Survival of Men withBRCA2 Mutations from Multiple Breast Cancer Families

Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers

Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.

High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer

Histopathological features of breast cancer in carriers of ATM gene variants

Improving mutation notification when new genetic information is identified in research: a trial of two strategies in familial breast cancer

Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells

Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk

Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation.

Monoclonal antibody CI-panHu defines a pan-human cell-surface antigen unique to higher primates.

Multifactorial likelihood assessment of BRCA1 and BRCA2 missense variants confirms that BRCA1:c.122A>G(p.His41Arg) is a pathogenic mutation

Overexpression of wild-type p53 in lichen sclerosus adjacent to human papillomavirus-negative vulvar cancer

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes

Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.

RAD21 overexpression is frequently observed in BRCA-X Prostate Cancers

Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer.

Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families

The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".

The kConFab experience – 14 years of biobanking.

The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cells

Whole-genome characterization of chemoresistant ovarian cancer

kConFab: A Familial Breast Cancer Consortium Facilitating Research and Translational Oncology